Boenning & Scattergood’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$235K Sell
5,311
-88
-2% -$3.81K 0.04% 355
2022
Q3
$209K Buy
+5,399
New +$217K 0.04% 346
2022
Q2
Sell
-5,311
Closed -$235K 378
2022
Q1
$235K Buy
5,311
+110
+2% +$4.77K 0.04% 355
2021
Q4
$221K Hold
5,201
0.04% 359
2021
Q3
$225K Hold
5,201
0.04% 347
2021
Q2
$222K Hold
5,201
0.04% 348
2021
Q1
$201K Buy
+5,201
New +$197K 0.04% 346

Other funds holding BSX

Boenning & Scattergood's BSX Position: Q4 2022 in Review

Boenning & Scattergood reduced its Boston Scientific (BSX) stake by 1.6% in Q4 2022, selling an estimated $3.81K and leaving 5,311 shares worth $235K. The position accounts for 0.04% of the portfolio, ranked #355.

Boenning & Scattergood first reported a position in BSX in Q1 2021 and has held it in 7 quarters since. 928 funds tracked by Wall St. Rank hold BSX as of Q4 2022.

  • Boenning & Scattergood held 5,311 shares of Boston Scientific worth $235K as of Q4 2022.
  • Boenning & Scattergood sold 88 Boston Scientific shares in Q4 2022, an estimated $3.81K.
  • Boston Scientific made up 0.04% of Boenning & Scattergood's portfolio in Q4 2022, its #355 holding.
  • Boenning & Scattergood first reported a position in Boston Scientific in Q1 2021 and has held it in 7 quarters since.
  • 928 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2022.

Based on Boenning & Scattergood's 13F filing for Q4 2022, filed 26 Jan 2023.